α-Ketoglutarate Attenuates Oxidative Stress-Induced Neuronal Aging via Modulation of the mTOR Pathway
Open Access
- 22 July 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (8) , 1080
Abstract
Background/Objectives: Oxidative stress constitutes a principal pathophysiological mechanism driving neurodegeneration and brain aging. α-Ketoglutarate (AKG), a key intermediate of the tricarboxylic acid (TCA) cycle, has shown potential in longevity and oxidative stress resistance. However, the role of AKG in oxidative stress-induced neuronal senescence and its interaction with the mTOR signaling pathway during neuronal aging remain poorly understood, posing a key challenge for developing senescence-targeted therapies. Methods: We investigated the neuroprotective effects of AKG using H2O2-induced senescence in HT22 cells and a D-galactose-induced brain aging mouse model. Assessments encompassed SA-β-gal staining, EdU incorporation, mitochondrial membrane potential (JC-1), and ROS measurement. Antioxidant markers, ATP levels, and the NAD+/NADH ratio were also analyzed. Proteomic profiling (DIA-MS) and KEGG/GSEA enrichment analyses were employed to identify AKG-responsive signaling pathways, and Western blotting validated changes in mTOR signaling and downstream effectors. Results: AKG significantly alleviated H2O2-induced senescence in HT22 cells, evidenced by enhanced cell viability, reduced ROS level, restored mitochondrial function, and downregulated p53/p21 expression. In vivo, AKG administration improved cognitive deficits and vestibulomotor dysfunction while ameliorating brain oxidative damage in aging mice. Proteomics revealed mTOR signaling pathways as key targets for AKG’s anti-aging activity. Mechanistically, AKG suppressed mTOR phosphorylation and activated ULK1, suggesting modulation of autophagy and metabolic homeostasis. These effects were accompanied by enhanced antioxidant enzyme activities and improved redox homeostasis. Conclusions: Our study demonstrates that AKG mitigates oxidative stress-induced neuronal senescence through suppression of the mTOR pathway and enhancement of mitochondrial and antioxidant function. These findings highlight AKG as a metabolic intervention candidate for age-related neurodegenerative diseases.Keywords
Funding Information
- Guangdong Basic and Applied Basic Research Foundation (2025A1515011819)
This publication has 44 references indexed in Scilit:
- Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and agingArchives of Toxicology, 2023
- Alpha-ketoglutarate supplementation and BiologicaL agE in middle-aged adults (ABLE)—intervention study protocolGeroScience, 2023
- Biochemical pathways to α-ketoglutarate, a multi-faceted metaboliteWorld Journal of Microbiology and Biotechnology, 2020
- d-galactose and aluminium chloride induced rat model with cognitive impairmentsBiomedicine & Pharmacotherapy, 2018
- mTOR Signaling in Growth, Metabolism, and DiseaseCell, 2017
- Glutamate and α-ketoglutarate: key players in glioma metabolismAmino Acids, 2016
- The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implicationsAmino Acids, 2016
- Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapyThe Journal of nutrition, health and aging, 2015
- The Hallmarks of AgingCell, 2013
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997